Habermann TM - Search Results

1

Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.

Winter JN, Li S, Aurora V, Variakojis D, Nelson B, Krajewska M, Zhang L, Habermann TM, Fisher RI, Macon WR, Chhanabhai M, Felgar RE, Hsi ED, Medeiros LJ, Weick JK, Weller EA, Melnick A, Reed JC, Horning SJ, Gascoyne RD. Winter JN, et al. Among authors: habermann tm. Clin Cancer Res. 2010 Apr 15;16(8):2435-42. doi: 10.1158/1078-0432.CCR-09-1219. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371683 Free PMC article. Clinical Trial.

2

Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM.

Gordon LI, Anderson J, Habermann TM, Winter JN, Glick J, Schilder RJ, Cassileth P. Gordon LI, et al. Among authors: habermann tm. J Clin Oncol. 1996 Apr;14(4):1275-81. doi: 10.1200/JCO.1996.14.4.1275. J Clin Oncol. 1996. PMID: 8648384 Clinical Trial.

3

Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.

Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC. Tallman MS, et al. Clin Cancer Res. 1999 Jul;5(7):1665-70. Clin Cancer Res. 1999. PMID: 10430066

4

A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity.

Gordon LI, Young M, Weller E, Habermann TM, Winter JN, Glick J, Ghosh C, Flynn P, Cassileth PA. Gordon LI, et al. Among authors: habermann tm. Blood. 1999 Nov 15;94(10):3307-14. Blood. 1999. PMID: 10552939 Free article. Clinical Trial.

5

Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.

Hogan WJ, Edwards WD, Macon WR, Habermann TM. Hogan WJ, et al. Among authors: habermann tm. Leuk Lymphoma. 2001 Sep-Oct;42(5):1145-50. doi: 10.3109/10428190109097738. Leuk Lymphoma. 2001. PMID: 11697635

6

Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493).

Sparano JA, Weller E, Nazeer T, Habermann T, Traynor AE, Manalo J, Cassileth P. Sparano JA, et al. Blood. 2002 Sep 1;100(5):1634-40. Blood. 2002. PMID: 12176882 Free article. Clinical Trial.

7

Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.

Horning SJ, Weller E, Kim K, Earle JD, O'Connell MJ, Habermann TM, Glick JH. Horning SJ, et al. Among authors: habermann tm. J Clin Oncol. 2004 Aug 1;22(15):3032-8. doi: 10.1200/JCO.2004.06.088. Epub 2004 Jun 21. J Clin Oncol. 2004. PMID: 15210738 Clinical Trial.

8

Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.

Ghobrial IM, Habermann TM, Ristow KM, Ansell SM, Macon W, Geyer SM, McGregor CG. Ghobrial IM, et al. Among authors: habermann tm. Leuk Lymphoma. 2005 Feb;46(2):191-6. doi: 10.1080/10428190400012011. Leuk Lymphoma. 2005. PMID: 15621801 Clinical Trial.

9

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, Walker RC, Ansell SM, Macon WR, Gores GG, Stegall MD, McGregor CG. Ghobrial IM, et al. Among authors: habermann tm. J Clin Oncol. 2005 Oct 20;23(30):7574-82. doi: 10.1200/JCO.2005.01.0934. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186599

10

Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.

McClure RF, Remstein ED, Macon WR, Dewald GW, Habermann TM, Hoering A, Kurtin PJ. McClure RF, et al. Among authors: habermann tm. Am J Surg Pathol. 2005 Dec;29(12):1652-60. doi: 10.1097/01.pas.0000180442.87022.08. Am J Surg Pathol. 2005. PMID: 16327438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters